GetTopicDetailResponse(id=cc701e6313a, topicName=Tolvaptan, introduction=Tolvaptan, content=null, image=null, comments=4, allHits=1124, url=https://h5.medsci.cn/topic?id=17631, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=9073, tagList=[TagDto(tagId=9073, tagName=Tolvaptan)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1707345, encodeId=26e01e0734589, content=<a href='/topic/show?id=cc701e6313a' target=_blank style='color:#2F92EE;'>#Tolvaptan#</a>, objectTitle=J Gastroenterol Hepatol：在肝硬化肝水腫患者中，血清尿素水平和尿鈉排泄與患者對tolvaptan藥物應(yīng)答密切相關(guān), objectType=article, longId=140407, objectId=74bc14040ecd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74bc14040ecd, replyNumber=0, likeNumber=97, createdTime=2019-02-10, rootId=0, userName=12498761m66暫無昵稱, userId=f0cf31405632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74bc14040ecd, moduleTitle=J Gastroenterol Hepatol：在肝硬化肝水腫患者中，血清尿素水平和尿鈉排泄與患者對tolvaptan藥物應(yīng)答密切相關(guān), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=74bc14040ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707344, encodeId=af331e073449e, content=<a href='/topic/show?id=cc701e6313a' target=_blank style='color:#2F92EE;'>#Tolvaptan#</a>, objectTitle=FDA批準(zhǔn)大冢tolvaptan用于治療常染色體顯性多囊腎病, objectType=article, longId=136505, objectId=b09113650549, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b09113650549, replyNumber=0, likeNumber=128, createdTime=2018-11-06, rootId=0, userName=12498761m66暫無昵稱, userId=f0cf31405632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b09113650549, moduleTitle=FDA批準(zhǔn)大冢tolvaptan用于治療常染色體顯性多囊腎病, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b09113650549)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707343, encodeId=3eb51e0734361, content=<a href='/topic/show?id=cc701e6313a' target=_blank style='color:#2F92EE;'>#Tolvaptan#</a>, objectTitle=J Gastroenterol Hepatol：BUN和尿鈉水平與肝硬化肝源性腹水患者對托伐普坦（tolvaptan）的反應(yīng)密切相關(guān), objectType=article, longId=123370, objectId=93821233e033, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93821233e033, replyNumber=0, likeNumber=107, createdTime=2018-07-30, rootId=0, userName=12498761m66暫無昵稱, userId=f0cf31405632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93821233e033, moduleTitle=J Gastroenterol Hepatol：BUN和尿鈉水平與肝硬化肝源性腹水患者對托伐普坦（tolvaptan）的反應(yīng)密切相關(guān), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=93821233e033)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707342, encodeId=6e7a1e07342d1, content=<a href='/topic/show?id=cc701e6313a' target=_blank style='color:#2F92EE;'>#Tolvaptan#</a>, objectTitle=大冢多囊腎藥物tolvaptan遭FDA顧問委員會否決, objectType=article, longId=22743, objectId=481f22e4325, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=481f22e4325, replyNumber=0, likeNumber=96, createdTime=2013-11-24, rootId=0, userName=12498761m66暫無昵稱, userId=f0cf31405632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=481f22e4325, moduleTitle=大冢多囊腎藥物tolvaptan遭FDA顧問委員會否決, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=481f22e4325)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
